MedTech News

New 4D brain map reveals potential early warning signs of multiple sclerosis
Using an animal model of multiple sclerosis (MS), researchers at the National Institutes of Health (NIH) have created a four-dimensional brain map that reveals how lesions similar to those seen in human MS form. These findings, published in Science, provide a window into the early disease state and could help identify potential targets for MS treatments and brain tissue repair.

Discovery of lung-based blood stem cells may transform transplant therapies
Red blood cells carry oxygen from the lungs to every other organ, and blood-forming stem cells must make about 200 billion new red blood cells each day to keep the oxygen flowing.

Scientists identify ‘inflammation’ gene that hastens aging
New therapies for managing aging could emerge from research into a new gene, which scientists have identified as a key driver of degeneration.

Can a smartwatch save your life? Google researchers develop smartwatch algorithm to detect cardiac arrest
A machine learning algorithm running on a smartwatch demonstrated the ability to detect sudden loss of pulse with high specificity (99.99%) and moderate sensitivity (67.23%), according to a study led by Google Research. Designed to identify cardiac arrest events, the system can automatically place an emergency call when it senses an event has occurred, even if the user is unresponsive.

An ancient RNA-guided system could simplify delivery of gene editing therapies
The programmable proteins are compact, modular, and can be directed to modify DNA in human cells.

Visby Medical™ Receives FDA Clearance and CLIA Waiver for Point-of-Care Respiratory Health Test
SAN JOSE, Calif., Feb. 26, 2025 /PRNewswire/ — Visby Medical™ announced today that it has received 510(k) clearance and was granted a CLIA waiver from the U.S. Food and Drug Administration (FDA) for its point-of-care respiratory health test. The Visby Medical Respiratory Health Test is a rapid polymerase chain reaction (PCR) test that detects and differentiates between upper respiratory infections caused by influenza (Flu) A & B, and SARS-CoV-2 (COVID-19). This multiplexed molecular device is the first handheld test to receive this designation after being granted Emergency Use Authorization (EUA) in December 2022.

Sway Medical, Inc. Announces FDA 510(k) Clearance of its Comprehensive Concussion Management System
TULSA, Okla., Feb. 26, 2025 /PRNewswire/ — Sway Medical, Inc., the company that created the Mobile Concussion Management category, is proud to announce that it has received FDA 510(k) clearance as a Computerized Cognitive Assessment Aid for Concussion under Section 882.1471. This clearance expands on Sway Medical’s previous FDA clearance for balance testing in head injuries, officially recognizing Sway as the first fully integrated tool that combines both cognitive and balance testing into one product for concussion management.

New blood test identifies organ aging, links to 30 future diseases
Our organs age at different rates, and a blood test determining how much they’ve each aged could predict the risk of conditions like lung cancer and heart disease decades later, finds a new study led by University College London (UCL) researchers.